Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $23.4600 (-2.13%) ($23.3500 - $24.3400) on Thu. May. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.24% (three month average) | RSI | 53 | Latest Price | $23.4600(-2.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.4% a day on average for past five trading days. | Weekly Trend | HALO advances 0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(46%) IWC(44%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -2.12% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) TLT(-2%) IGOV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.12% (StdDev 4.24%) | Hourly BBV | 0 () | Intraday Trend | -2.7% | | | |
|
Resistance Level | $23.87 | 5 Day Moving Average | $24.16(-2.9%) | 10 Day Moving Average | $24.04(-2.41%) | 20 Day Moving Average | $23.87(-1.72%) | To recent high | -5.5% | To recent low | 68.8% | Market Cap | $3.206b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |